Quantcast
Information About Cancer And Oncology That Everyone Should

Information About Cancer And Oncology That Everyone Should Know

Rayshell Clapper for redOrbit.com - Your Universe Online Cancer is a real concern for many people. The concern may come from a genetic predisposition, environmental triggers, or simply the health-conscious need to have a better understanding of...

Latest chemotherapy Stories

2014-10-30 12:29:56

HOUSTON, Oct. 30, 2014 /PRNewswire-USNewswire/ -- Improved surgical outcomes for ovarian cancer, expanded potential impact for new drugs, and a novel family outreach program to head off cancers fueled by known genetic risk mutations are among the early innovations of The University of Texas MD Anderson Cancer Center's Moon Shots Program. First-of-a-kind combination clinical trials; advanced molecular analysis to guide treatment and screening; and a focused program to gather, store, access...

2014-10-30 08:33:52

LOS ANGELES, Oct. 30, 2014 /PRNewswire/ -- CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced an upcoming presentation highlighting its novel technology and its lead drug candidate, aldoxorubicin. The presentation, titled, "Drug Conjugates Bind Covalently to Albumin: A New Approach," will be given by Sant P. Chawla, M.D., F.R.A.C.P., Director of the Sarcoma Oncology Center and principal investigator of the...

2014-10-29 08:34:22

This Year Marks the 20th Anniversary of LLS's Prestigious Translational Research Program WHITE PLAINS, N.Y., Oct. 29, 2014 /PRNewswire-USNewswire/ -- The Leukemia & Lymphoma Society (LLS) is awarding $15.6 million in academic grants to 26 scientists who have proposed innovative laboratory research that shows promise in leading to new treatments for blood cancer patients. The funds are being awarded through LLS's Translational Research Program (TRP), which aims to accelerate...

2014-10-28 23:03:54

Researchers demonstrate the rapid spread of viruses in 2-4 hours; Clearstream provides antibacterial and antimicrobial products to combat viral contamination. Harrisburg, NC (PRWEB) October 28, 2014 Researchers at the University of Arizona, Tucson, recently revealed the results of a new study on viral contamination, presenting their findings at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in September. In response to the study, Clearstream, LLC – a...

2014-10-23 12:29:06

CARMEL, Ind., Oct. 23, 2014 /PRNewswire/ -- Sylvia Rosenberg was 27 when she found a lump in her right breast. A biopsy confirmed she had early stage breast cancer. Her doctor recommended a lumpectomy followed by chemotherapy and hormone therapy. Sylvia had watched her aunt battle breast cancer, and she was determined to find a better treatment. Her research confirmed that SonoPhoto Dynamic Therapy (SPDT) combined with hyperthermia had a better success rate than conventional...

2014-10-23 08:37:02

LUGANO, Switzerland, October 23, 2014 /PRNewswire/ -- ~ At a dose of 20 mug/kg, Palonosetron, administered as a singledose, is as effective as ondansetron 0.15 mg/kg given three times a day to a maximum dose of 32mg ~ No safety concerns were raised by the study Helsinn Group, the company focused on building quality cancer care, presented data at the International Society of Paediatric Oncology (SIOP) congress establishing that palonosetron, at a dose 20 mug/kg, is a...

2014-10-22 20:23:18

LONDON, Oct. 22, 2014 /PRNewswire/ -- Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H2, 2014 SummaryGlobalData's clinical trial report, "Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H2, 2014" provides data on the Chemotherapy Induced Peripheral Neuropathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chemotherapy Induced Peripheral Neuropathy. It includes an...

2014-10-16 23:03:38

Lawrence Livermore biomedical researcher Mike Malfatti is working with two researchers at the University of California, Davis, Comprehensive Cancer Center to leverage dramatic advances in biological accelerator mass spectrometry (AMS) to see how cancer patients respond to the chemotherapeutic drug carboplatin. Livermore, California (PRWEB) October 16, 2014 Buoyed by several dramatic advances, Lawrence Livermore National Laboratory scientists think they can tackle biological science in a...

2014-10-14 12:30:20

CINCINNATI, Oct. 14, 2014 /PRNewswire-USNewswire/ -- Doctors at Cincinnati Children's Hospital Medical Center have developed a new technique for treating the eye cancer retinoblastoma to improve the odds for preventing eye loss, blindness or death in children with advanced forms of the disease. Treatments for retinoblastoma have progressed dramatically in recent years, one being a procedure called ophthalmic artery infusion chemotherapy. A tiny catheter is inserted into an artery...

2014-10-14 08:33:18

SAN RAFAEL, Calif., Oct. 14, 2014 /PRNewswire/ -- Sanovas Inc., a Life Science company accelerating the development and commercialization of next-generation microinvasive diagnostics, devices and drug delivery technologies, announced today that US Patent No. 8,834,544 has issued to the Company. Photo - http://photos.prnewswire.com/prnh/20141013/151744 Logo - http://photos.prnewswire.com/prnh/20141013/151743LOGO The patent, entitled "Photodynamic Therapy for Tumors...


Latest chemotherapy Reference Libraries

Intravenous Therapy
2013-04-30 13:16:16

Intravenous therapy, commonly known as IV therapy, is known as the administration of a liquid substance directly into a vein. It is also known as drip therapy, because most often the liquid is suspended above the IV site by an infusion pump, and runs through a drip chamber, which prevents air from entering the line. IVs are the preferred method of drug administration in hospital settings because they are the fastest known route of getting medication to the body. Intravenous therapy can also...

Antiviral Chemistry & Chemotherapy
2012-04-25 09:59:26

Antiviral Chemistry & Chemotherapy is a peer-reviewed academic journal published bi-monthly by International Medical Press in London since 1997. When founded in January 1990, it was published by Blackwell Science. The current editor-in-chief is Hugh J. Field of University of Cambridge, UK. The journal publishes primary papers and reviews on all aspects of the preclinical development of antiviral agents, including their chemical synthesis, biochemistry, pharmacology, mode of action and...

More Articles (2 articles) »
Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related